4.7 Article Proceedings Paper

Advances in bipolar disorder: selected sessions from the 2011 International Conference on Bipolar Disorder

期刊

ANNALS MEETING REPORTS
卷 1242, 期 -, 页码 1-25

出版社

BLACKWELL SCIENCE PUBL
DOI: 10.1111/j.1749-6632.2011.06336.x

关键词

bipolar disorders; medical comorbidity; neuroscience; diagnosis

资金

  1. AstraZeneca LP
  2. Merck Sharp & Dohme Corporation
  3. Bristol-Myers Squibb
  4. Cyberonics, Inc.
  5. Community Care Behavioral Health Organization (an affiliate of the UPMC Health Plan)
  6. Fine Foundation
  7. Staunton Farm Foundation

向作者/读者索取更多资源

Recently, the 9th International Conference on Bipolar Disorder (ICBD) took place in Pittsburgh, PA, June 9-11, 2011. The conference focused on a number of important issues concerning the diagnosis of bipolar disorders across the life span, advances in neuroscience, treatment strategies for bipolar disorders, early intervention, and medical comorbidity. Several of these topics were discussed in four plenary sessions. This meeting report describes the major points of each of these sessions and included (1) strategies for moving biology forward; (2) bipolar disorder and the forthcoming new DSM-5 nomenclature; (3) management of bipolar disorders-both theory and intervention, with an emphasis on the medical comorbidities; and, (4) a review of several key task force reports commissioned by the International Society for Bipolar Disorder (ISBD).

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据